Cristina Cruz Zambrano
Member of the Cancer profiling research line
Email: cristina.cruz@umedicina.cat
ORCID: 0000-0002-6474-7504
Scientific Profile: URECERCA
Cristina Cruz is a lecturer at the University of Vic – Central University of Catalonia (UVic-UCC). Her research focuses on cancer biomarkers of prognosis and treatment response.
She graduated in Biochemistry in 1996 (University of Barcelona) and earned the doctorate in Biochemistry in 2001. In 2006 she graduated in Medicine (University of Barcelona) and is a Medical Oncology specialist since 2011. From 2011 to 2018 she was a clinical and translational investigator at Vall d’Hebron Institute of Oncology (VHIO). She participated in a number of clinical trials in the field of early drug development (Phase I) and Phase II & III clinical trials investigating targeted therapies for hereditary breast and ovarian cancers. As a postdoctoral researcher from VHIO’s Experimental Therapeutics Group, she also developed translational projects to investigate the determinants of treatment response and resistance among BRCA1/2 germline mutation carriers, including the functional biomarker RAD51. In 2019, she joined the Faculty of Medicine at UVic-UCC, where she teaches Human Genetics, Histology, Medical Embryology and Physiology.
My last happenings:
Maria José Gil’s Commitment to Advancing Wound Care Education
Beyond her research activity within TR2Lab, PhD candidate Maria José Gil has played an active role this year in training healthcare professionals across several educational initiatives in the field of wound care, reaching nurses, nursing residents, and healthcare assistants throughout different regions. FOCUSS Training Programmes (IACS) Maria José coordinated and delivered two continuing professional development programmes promoted by the Aragonese Institute of Health Sciences (IACS), part of the FOCUSS Programme, which offers healthcare professionals practical training placements in reference units. The Advanced Wound Care Techniques programme, delivered in three editions with two registered nurses per edition, combined theoretical and hands-on [...]
Juan Crespo wins Santander X Spain Awards 2026 with the Phygital Bone project
Dr. Juan Crespo, member of the TR2Lab research group, has been named one of the three winners of the Santander X Spain Awards | Proyectos Emprendedores Universitarios 2026, a competition that supports university entrepreneurial talent and showcases innovative projects with social, business, and technological impact. Crespo's winning project, Phygital Bone, is a deep-tech scientific and medical platform focused on severe bone reconstruction. The project combines 3D computational design algorithms, new biomaterials, and bioprinting of personalized implants to address complex bone regeneration challenges. The award was granted following the presentation of eleven finalist projects, held online on June 18th in a [...]
Dr. Anna Fàbrega Presents TR2Lab’s New Research Line on the Microbiome in Complex Wounds
Dr. Anna Fàbrega participated as an invited speaker at the I Jornada Ferides 360: experiència, coneixement i innovació - Parc Sanitari Sant Joan de Déu, where she presented TR2Lab’s new research line focused on the study of the microbiome in complex wounds. During her presentation, she introduced the multicentre project she leads, which aims to longitudinally analyse the intestinal and skin microbiome of patients with diabetic foot ulcers. The study seeks to identify microbial patterns associated with the clinical progression of these lesions, with the goal of improving patient stratification and moving towards a more personalized approach to the management [...]
